Technology
Neuralink’s China Rival Targets Obesity With ‘Electronic’ GLP-1
Amber Tong and Tom Giles·Bloomberg·November 3, 2026

Chinese neurotechnology firm BrainCo is developing a wearable device that it says could suppress appetite by stimulating the brain, positioning it as a potential non-drug alternative to blockbuster GLP-1 weight-loss treatments.
Read the full story at Bloomberg →